WTA begins mandatory gene testing for players in Cincinnati

The Women’s Tennis Association (WTA) has begun implementing a mandatory genetic testing policy in Cincinnati to detect the SRY gene, a DNA segment typically found on the Y chromosome. The policy requires a one-time test via blood or cheek swab to verify eligibility for women-only tournaments.

Player reactions are divided. Jessica Pegula reported that the initial rollout has been smooth and simple, noting that she has not heard complaints from those who have already undergone testing. World No. 1 Aryna Sabalenka has championed the measure as a way to ensure fairness in competition. Coco Gauff has also expressed support for competitive equality while remaining cautious about the impact on the transgender community.

Conversely, a coalition led by the Sport & Rights Alliance has called for the WTA to suspend the measure, citing concerns over the lack of athlete involvement in the decision-making process and the potential for stigmatization. Additionally, ILGA World has criticized the policy, noting that there are currently no openly transgender women competing on the professional circuit and questioning the necessity of universal testing.